by Tokyo Chemical Industry
We offer a series of high performance ODS columns with different specifications capable of analyzing virtually all kinds of organic compound.
Our products are supported by extensive research and development, and experience in advanced synthetic technology.
Monomeric ODS is bonded to pure silicagel which gives the stationary phase unique ODS properties without other retention mechanisms after advanced end-capping procedure.
Good reproducibility and high number of theoretical plate.
Competitive price.
Features
1.Good reproducibility from batch to batch.
2.Improved separation by high number of theoretical plate.
3.Competitive prices.
Analytes: hydrohobic compounds
| Vendor | Tokyo Chemical Industry | Internal Diameter | |
| Brand | Kaseisorb LC ODS 2000 | Pore size | 120 |
| Modifification | Silica/C18 | pH stability from | 2.5 |
| Mode | Reversed-Phase | pH stability to | 7.5 |
| Particle Size | Carbon Load, % | 17.0 | |
| Length | Endcapped | Yes |
| Vendor | Brand | Mode | Modification | Int. diam. | Length | Particles | Pores | Price |
|---|---|---|---|---|---|---|---|---|
| GRACE | VisionHT C18 Classic | Reversed-Phase | Silica/C18 | 2.0 mm | 100 mm | 1.5 μm | 100 Å | On request |
| GRACE | VisionHT C18 Classic | Reversed-Phase | Silica/C18 | 7.0 mm | 53 mm | 3.0 μm | 100 Å | On request |
| Bonna-Agela Technologies | Durashell RP | Reversed-Phase | Silica/C18 | 4.6 mm | 150 mm | 3.0 μm | 150 Å | On request |
| Princeton Chromatography Inc. | PrincetonSPHER C18-300 | Reversed-Phase | Silica/C18 | 21.2 mm | 150 mm | 10.0 μm | 300 Å | On request |
| WATERS | Symmetry C18 | Reversed-Phase | Silica/C18 | 2.1 mm | 150 mm | 3.5 μm | 100 Å | On request |
| Thermo Fisher Scientific | BetaMax | Reversed-Phase | Silica/C18 | 1.0 mm | 50 mm | 5.0 μm | 60 Å | On request |
| Teknokroma | Hyperpack BASIC ODS | Reversed-Phase | Silica/C18 | 4.0 mm | 30 mm | 3.0 μm | 130 Å | On request |
| ACE | ACE C18-HL | Reversed-Phase | Silica/C18 | 1.0 mm | 30 mm | 3.0 μm | 90 Å | On request |
No customer reviews yet. Be the first to share your experience!
Reach thousands of researchers worldwide. Fill in your details and our team will contact you shortly.
Drugs, Pharmaceuticals